During the past decade, Texas Oncology conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 21 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 11 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Oncology" #1 sponsor was "Bristol-Myers Squibb" with 9 trials, followed by "Celgene" with 5 trials sponsored, "US Oncology Research" with 5 trials sponsored, "Agennix" with 3 trials sponsored and "Eisai Inc." with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Sanofi" with 2 trials as a collaborator and "US Oncology Research" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Texas Oncology" are "Metastatic Breast Cancer" (6 trials), "Multiple Myeloma" (5 trials), "Breast Cancer" (4 trials), "Metastatic Colorectal Cancer" (3 trials) and "Prostate Cancer" (3 trials). Many other conditions were trialed in "Texas Oncology" in a lesser frequency.

Most popular intervention types in "Texas Oncology" are "Drug" (57 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (5 trials), "Nivolumab" (5 trials), "Placebo" (5 trials), "Dexamethasone" (4 trials) and "Paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Texas Oncology" are 49 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Texas Oncology". undefined are not yet recruiting, 8 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 33 completed trials in Texas Oncology, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Oncology, 10 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".